Join the 'Alzheimer's Disease' group to help and get support from people like you.

Alzheimer's Disease Blog

Related terms: Presenile Dementia, SDAT, Senile dementia Alzheimer's Type, Alzheimers

Vitamin B No Help for Alzheimer's: Review

Posted 15 days ago by Drugs.com

WEDNESDAY, July 16, 2014 – Taking B vitamins does not slow age-related mental decline or prevent Alzheimer's disease, a new review says. People with Alzheimer's have high blood levels of a compound called homocysteine, and people with elevated levels of the compound have been shown to be at higher risk for Alzheimer's. It's known that folic acid (vitamin B-9) and vitamin B-12 lower homocysteine levels, so it was believed that taking B vitamins may lower a person's risk of Alzheimer's. However, this review, published recently in the American Journal of Clinical Nutrition, revealed different results. "It would have been very nice to have found something different," study leader Dr. Robert Clarke, of Oxford University in England, said in a university news release. "Our study draws a line under the debate: B vitamins don't reduce cognitive decline as we age. Taking folic acid and vitamin ... Read more

Related support groups: Alzheimer's Disease, Vitamin B12, Cyanocobalamin, Vitamin B-12, Hydroxocobalamin, B-12 Dots, Crysti-12, Big Shot B-12, Neo-Cytamen, Cyanokit, Cobal 1000, Sytobex, Depo-Cobolin, Rubesol-1000, Cobolin-M, Vita 12, Hydroxy-Cobal, Crystamine, B-12 Resin, Nascobal

Researchers Spot Potential New Culprit Behind Alzheimer's

Posted 15 days ago by Drugs.com

WEDNESDAY, July 16, 2014 – Although the exact reason why Alzheimer's disease develops still remains elusive, scientists report that they've found a new protein that may play an important role in the devastating memory illness. What they don't yet know is whether or not this new protein – called TDP-43 – is a cause of Alzheimer's disease, or if it's something that develops due to Alzheimer's disease. It's too early to know if this finding could have any effect on the diagnosis, treatment or prevention of Alzheimer's disease. For now, "we really need to understand what this protein is doing and its relationship to other proteins," said the study's lead author Dr. Keith Josephs, a professor of neurology at the Mayo Clinic in Rochester, Minn. Scientists studying Alzheimer's disease have long been interested in two types of proteins in the brain known as beta-amyloid and tau. In ... Read more

Related support groups: Alzheimer's Disease

Alzheimer's Rate Falling in the United States, Studies Show

Posted 16 days ago by Drugs.com

TUESDAY, July 15, 2014 – The number of new cases of dementia has been declining in recent decades in the United States, Germany and other developed countries, a trio of new studies shows. In one U.S. study, researchers found that compared with the late 1970s, the rate of dementia diagnosis was 44 percent lower in recent years. The sharpest decline was seen among people in their 60s. A second study, which reviewed research from England, the Netherlands, Sweden and the United States, found a similar pattern. The third study, meanwhile, found signs of progress in the space of only a few years: In 2004, older German adults were about one-quarter more likely to be diagnosed with dementia than in 2007. "This is some good news," said Dean Hartley, director of science initiatives for the nonprofit Alzheimer's Association. The three studies are being presented Tuesday at the Alzheimer's ... Read more

Related support groups: Alzheimer's Disease

Staying Active May Help Prevent Dementia

Posted 17 days ago by Drugs.com

MONDAY, July 14, 2014 – Being physically active in middle age appears to help reduce your risk for Alzheimer's disease and other types of dementia, suggest the findings from two new studies. "In our studies, we found that physical exercise at various levels, especially in midlife, is beneficial for cognitive function," Dr. Yonas Geda from the Mayo Clinic, said in an Alzheimer's Association news release. "These are intriguing results, but they are not yet conclusive. More research is needed to determine the extent and nature of physical activity in protecting against MCI [mild cognitive impairment] and dementia," Geda added. One study included 280 seniors who were asked about their physical activity levels over their lifetime. The median age of the study volunteers was 81, which means half were under that age and half were older than 81. All of the study participants had early signs of ... Read more

Related support groups: Dementia, Alzheimer's Disease

Eye Tests Might Help ID Alzheimer's, Studies Suggest

Posted 17 days ago by Drugs.com

SUNDAY, July 13, 2014 – Eye tests could be used to identify people in the early stages of Alzheimer's disease, two new studies suggest. In one study, early results from 40 participants who used a certain eye test found a significant association between levels of beta-amyloid plaques in the retina of the eye and levels of the plaques in the brain. Beta-amyloid plaques in the brain are associated with Alzheimer's disease. This type of eye test could be used in conjunction with the brain scans and clinical tests currently relied on to diagnose Alzheimer's, study author Shaun Frost, of the Commonwealth Scientific and Industrial Research Organization in Australia, said in a news release from the Alzheimer's Association. The eye test could also be used to monitor the progression of Alzheimer's and a patient's response to treatment, Frost added. The preliminary results were scheduled for ... Read more

Related support groups: Alzheimer's Disease, Diagnosis and Investigation

Could a Simple Smell Test Help Spot Alzheimer's Early?

Posted 17 days ago by Drugs.com

SUNDAY, July 13, 2014 – New research suggests that a faltering sense of smell might signal the early stages of Alzheimer's disease, and that an inexpensive, low-tech smell test could spot who needs more extensive screening for dementia. In two different studies, the decreased ability to identify odors was associated with the loss of brain cell function and progression to Alzheimer's disease. "We're trying to be able to diagnose Alzheimer's earlier and theoretically deliver drugs to people sooner," said Matthew Growdon, lead author of one of the studies. "Think about cardiovascular disease as a paradigm; the idea is that we would find a way to control the risk factors [before the disease advances]." The ability to smell is associated with the first cranial nerve, and is often one of the first things to be affected by cognitive decline. Brain regions that process odors are particularly ... Read more

Related support groups: Alzheimer's Disease, Diagnosis and Investigation

Yoga, Meditation May Help Dementia Patients and Caregivers Alike

Posted 5 Jun 2014 by Drugs.com

THURSDAY, June 5, 2014 – Life with Alzheimer's disease or other dementias can be difficult for the affected individual and his or her caregiver. But a small British study suggests that a "holistic" program involving yoga, meditation and other interventions can ease the burden for both. "This is an activity that caregivers and patients can do together," said study lead author Yvonne J-Lyn Khoo, a researcher with the Health and Social Care Institute at Teesside University in Middlesbrough, U.K. "Because everyone is doing the program together, caregivers have peace of mind to at least allow themselves to 'let go' and do some exercise." One expert in the United States said programs like this are sorely needed. "Caregivers for people with dementia are under so much stress," said Catherine Roe, an assistant professor of neurology at Washington University School of Medicine in St. Louis. ... Read more

Related support groups: Dementia, Alzheimer's Disease

Anti-Alzheimer's Drug Shows Promise in Mice Study

Posted 3 Jun 2014 by Drugs.com

TUESDAY, June 3, 2014 – Researchers working with mice have identified a drug they believe holds promise as a preventive treatment for Alzheimer's disease. In the study, the compound cut levels of amyloid beta – a protein associated with this degenerative brain disease – by about half, the researchers said. Years before Alzheimer's develops, amyloid beta starts to build up and clump in the brain. Scientists believe that helping the brain remove this protein in late middle age might ward off the disease. Preventing Alzheimer's may be more feasible than stopping it once it develops and damages the brain, the NYU Langone Medical Center researchers said. "The key is to prevent the disease process from going that far," said the study's leader, Dr. Martin Sadowski, associate professor of neurology, psychiatry, and biochemistry and molecular pharmacology. A treatment based on this compound, ... Read more

Related support groups: Alzheimer's Disease

Could Certain Antidepressants Slow Alzheimer's?

Posted 14 May 2014 by Drugs.com

WEDNESDAY, May 14, 2014 – Preliminary research suggests that the commonly used antidepressant Celexa, and perhaps other drugs in its class, may temporarily lower levels of a protein that clogs the brains of people with Alzheimer's disease. It's too early to know if the medication – or the drugs that are similar to it – could play a role in the prevention of the devastating brain-robbing disease. The authors of the new study only looked at the effects of a large dose of the drug for less than two days, and only healthy younger people took part in the research. There's another important caveat: Previous efforts to reduce the levels of the protein, known as beta amyloid, haven't helped patients fend off Alzheimer's. And Celexa can cause some potentially serious side effects. Still, "this is the first step in trying to move toward a preventive treatment," said study author Dr. Yvette ... Read more

Related support groups: Lexapro, Zoloft, Prozac, Celexa, Paxil, Citalopram, Sertraline, Fluoxetine, Escitalopram, Alzheimer's Disease, Paroxetine, Luvox, Brintellix, Paxil CR, Fluvoxamine, Sarafem, Luvox CR, Brisdelle, Pexeva, Vortioxetine

Brain Stimulation Shows Early Promise Against Alzheimer's

Posted 6 May 2014 by Drugs.com

TUESDAY, May 6, 2014 – Four of six Alzheimer's patients responded to deep brain stimulation in a pilot study, German researchers report. Meanwhile, 42 Alzheimer's patients in the United States and Canada have been enrolled in the largest study to date to examine the use of deep brain stimulation to treat the disease. There are caveats about the research, even though deep brain stimulation is already used as a treatment for Parkinson's disease. "The research is very preliminary. We have good intentions, but there has to be rigorous testing with a 'control' group," said Dr. Stephen Salloway, director of neurology and the Memory and Aging Program at Brown University, in Rhode Island. Still, "we're opening a new era of exploration for Alzheimer's treatment," said Salloway, who studies brain stimulation. His hospital, Butler Hospital in Providence, R.I., is taking part in the new, larger ... Read more

Related support groups: Alzheimer's Disease

Alzheimer's Variation May Often Go Unrecognized: Study

Posted 2 May 2014 by Drugs.com

FRIDAY, May 2, 2014 – Many patients with a newly identified subtype of Alzheimer's disease are misdiagnosed and don't receive proper treatment, researchers report. They analyzed the brains of more than 1,800 Alzheimer's patients and found that 11 percent of them had this subtype, called "hippocampal sparing Alzheimer's disease." About 5.2 million Americans have Alzheimer's, which means that nearly 600,000 of them could have this variant of the disease, according to the research team at the Mayo Clinic in Florida. The findings were scheduled for presentation Thursday at the annual meeting of the American Academy of Neurology, in Philadelphia. People with hippocampal sparing Alzheimer's tend to be men and they are afflicted at a much younger age than other Alzheimer's patients, the study found. The symptoms of this subtype are often quite different from the most common form of the ... Read more

Related support groups: Alzheimer's Disease

More Research Links Poor Heart Health With Alzheimer's Risk

Posted 31 Mar 2014 by Drugs.com

MONDAY, March 31, 2014 – A new study links heart disease with increased odds of developing dementia. Researchers found that artery stiffness – a condition called atherosclerosis – is associated with the buildup of beta-amyloid plaque in the brain, a hallmark of Alzheimer's disease. "This is more than just another example of how heart health relates to brain health. It is a signal that the process of vascular aging may predispose the brain to increased amyloid plaque buildup," said lead researcher Timothy Hughes, from the department of internal medicine at Wake Forest University in Winston-Salem, N.C. Plaque builds with age and appears to worsen in those with stiffer arteries, he said. "Finding and preventing the causes of plaque buildup is going to be an essential factor in the prevention of Alzheimer's disease and extending brain health throughout life," Hughes added. Alzheimer's ... Read more

Related support groups: Heart Disease, Dementia, Alzheimer's Disease

FDA Approves Neuraceq (florbetaben F18 injection) for PET Imaging of Beta-Amyloid Plaques

Posted 20 Mar 2014 by Drugs.com

Berlin/Boston, March 20, 2014‒ Piramal Imaging today announced that the U.S. Food and Drug Administration (FDA) has approved Neuraceq. This approval comes only four weeks after receiving marketing authorization for Neuraceq from the European Commission. Neuraceq is indicated for Positron Emission Tomography (PET) imaging of the brain to estimate beta-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline. There are an estimated 7.7 million new cases of dementia each year worldwide. 1 Alzheimer’s disease accounts for 60-80% of all dementia diagnoses. 2 However, a clinical diagnosis of probable AD is incorrect upon post-mortem histological investigation in 10-30% of cases.3 The Centers for Medicare & Medicaid Services (CMS) has declared it will cover a beta-amyloid PET scan fo ... Read more

Related support groups: Dementia, Alzheimer's Disease, Diagnosis and Investigation, Positron Emission Tomography Imaging

Alzheimer's Strikes Women Harder Than Men: Report

Posted 19 Mar 2014 by Drugs.com

WEDNESDAY, March 19, 2014 – A 65-year-old American woman has a 1 in 6 chance of developing Alzheimer's disease later in life, while a man the same age has about a 1 in 11 chance. That's one of the key findings of a new report that highlights the heavy toll that Alzheimer's takes on women as both patients and caregivers. Women in their 60s are also twice as likely to develop Alzheimer's than breast cancer, according to the report – "2014 Alzheimer's Disease Facts and Figures" – from the Alzheimer's Association. The report also found that there are 2.5 times more women than men providing 24-hour care for a loved one with Alzheimer's. Women caregivers are also more likely than men to switch from full-time to part-time work (20 percent versus 3 percent), more likely to take a leave of absence (18 percent versus 11 percent), and to stop working (11 percent versus 5 percent) to meet the ... Read more

Related support groups: Alzheimer's Disease

Alzheimer's May Kill Far More Americans Than Thought

Posted 5 Mar 2014 by Drugs.com

WEDNESDAY, March 5, 2014 – The number of lives lost to Alzheimer's disease each year may be far more than thought, and it might rival heart disease and cancer as one of the top killers of Americans, new research suggests. Combing through data on nearly 2,600 older adults, scientists from Rush University Medical Center in Chicago estimated that more than one-third of all deaths in people aged 75 and older were attributable to Alzheimer's, and the death toll from the incurable brain disease exceeds statistics gleaned from death certificates. Alzheimer's disease affects an estimated 5 million Americans over age 65, and currently ranks as the sixth leading cause of death in the United States. Although official statistics blame Alzheimer's for about 85,000 deaths each year, the study authors estimated the true toll to be closer to 500,000. "A lot of people don't recognize that Alzheimer's ... Read more

Related support groups: Alzheimer's Disease

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Dementia

Related Drug Support Groups

Aricept, Namenda, Exelon, donepezil, vitamin e, memantine, galantamine, Namenda XR, Reminyl, view more... etanercept, Hydergine, rivastigmine, Axona, Razadyne, Razadyne ER, tacrine, Alpha E, Aquasol E, Cognex, Hydergine LC, Aqua-E, Aquavite-E, E-Gems, Gerimal, E-600, Aricept ODT, E Pherol, caprylidene, ergoloid mesylates, Amino-Opti-E, Vita-Plus E Natural, E-400 Clear, Nutr-E-Sol, Centrum Singles-Vitamin E